Steven Binder obtained his BA in History and Science from Harvard University. After working for several years in diagnostic laboratories, he joined the research group at Bio-Rad Laboratories in 1983. He has developed screening tests that are widely used for hemoglobinopathies, pheochromocytoma, and infectious diseases. Since 1998 he has pioneered the clinical application of multiplex technology for autoimmunity testing. His research has been published in The Journal of Rheumatology, Lupus, Autoimmunity Reviews, and many other journals.